{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:42:08Z","timestamp":1785163328861,"version":"3.55.0"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>Breast cancer is the most common cancer that affects women globally and is among the leading cause of women\u2019s death. Triple-negative breast cancer is more difficult to treat because hormone therapy is not available for this subset of cancer. The well-established therapy against triple-negative breast cancer is mainly based on surgery, chemotherapy, and immunotherapy. Among the drugs used in the therapy are cisplatin and carboplatin. However, they cause severe toxicity to the kidneys and brain and cause nausea. Therefore, it is urgent to propose new chemotherapy techniques that provide new treatment options to patients affected by this disease. Nowadays, peptide drugs are emerging as a class of promising new anticancer agents due to their lytic nature and, apparently, a minor drug resistance compared to other conventional drugs (reviewed in <jats:xref>Jafari et al., 2022<\/jats:xref>). We have recently reported the cytotoxic effect of the antimicrobial peptide LyeTx I-b against glioblastoma cells (<jats:xref>Abdel-Salam et al., 2019<\/jats:xref>). In this research, we demonstrated the cytotoxic effect of the peptide LyeTx I-b, alone and combined with cisplatin, against triple-negative cell lines (MDA-MD-231). LyeTx-I-b showed a selectivity index 70-fold higher than cisplatin. The peptide:cisplatin combination (P:C) 1:1 presented a synergistic effect on the cell death and a selective index value 16 times greater than the cisplatin alone treatment. Therefore, an equi-effective reduction of cisplatin can be reached in the presence of LyeTx I-b. Cells treated with P:C combinations were arrested in the G2\/M cell cycle phase and showed positive staining for acridine orange, which was inhibited by bafilomycin A1, indicating autophagic cell death (ACD) as a probable cell death mechanism. Furthermore, Western blot experiments indicated a decrease in P21 expression and AKT phosphorylation. The decrease in AKT phosphorylation is indicative of ACD. However, other studies are still necessary to better elucidate the pathways involved in the cell death mechanism induced by the peptide and the drug combinations. These findings confirmed that the peptide LyeTx I-b seems to be a good candidate for combined chemotherapy to treat breast cancer. In addition, <jats:italic>in vivo<\/jats:italic> studies are essential to validate the use of LyeTx I-b as a therapeutic drug candidate, alone and\/or combined with cisplatin.<\/jats:p>","DOI":"10.3389\/fmolb.2022.876833","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T07:29:23Z","timestamp":1651649363000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["LyeTxI-b, a Synthetic Peptide Derived From a Spider Venom, Is Highly Active in Triple-Negative Breast Cancer Cells and Acts Synergistically With Cisplatin"],"prefix":"10.3389","volume":"9","author":[{"given":"Joaquim Teixeira de","family":"Avelar J\u00fanior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edleusa","family":"Lima-Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lio Jos\u00e9","family":"Castro Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano Monteiro de Castro","family":"Pimenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel Gouv\u00eaa","family":"Dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine Maria","family":"Souza-Fagundes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"De Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrc2657","article-title":"p21 in Cancer: Intricate Networks and Multiple Activities","volume":"9","author":"Abbas","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00726-018-2678-4","article-title":"The Synthetic Peptide LyeTxI-B Derived from Lycosa Erythrognatha Spider Venom Is Cytotoxic to U-87 MG Glioblastoma Cells","volume":"51","author":"Abdel-Salam","year":"2019","journal-title":"Amino Acids"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3390\/antibiotics10091136","article-title":"LyeTx I-B Peptide Attenuates Tumor Burden and Metastasis in a Mouse 4T1 Breast Cancer Model","volume":"10","author":"Abdel-Salam","year":"2021","journal-title":"Antibiotics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1200\/EDBK_159135","article-title":"The Evolution of Triple-Negative Breast Cancer: From Biology to Novel Therapeutics","volume":"35","author":"Anders","year":"2016","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"B5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.mad.2016.07.006","article-title":"Cell-cycle Involvement in Autophagy and Apoptosis in Yeast","volume":"161","author":"Azzopardi","year":"2017","journal-title":"Mech. Ageing Development"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/cncr.22618","article-title":"Descriptive Analysis of Estrogen Receptor (ER)-negative, Progesterone Receptor (PR)-negative, and HER2-Negative Invasive Breast Cancer, the So-Called Triple-Negative Phenotype","volume":"109","author":"Bauer","year":"2007","journal-title":"Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA: A Cancer J. Clinicians"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/srep05749","article-title":"Clioquinol Induces Pro-death Autophagy in Leukemia and Myeloma Cells by Disrupting the mTOR Signaling Pathway","volume":"4","author":"Cao","year":"2015","journal-title":"Sci. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.7150\/thno.16358","article-title":"Targeting Negative Surface Charges of Cancer Cells by Multifunctional Nanoprobes","volume":"6","author":"Chen","year":"2016","journal-title":"Theranostics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in Cancer Therapy: Molecular Mechanisms of Action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"13943","DOI":"10.1073\/pnas.1903297116","article-title":"A Structure-Based Mechanism of Cisplatin Resistance Mediated by Glutathione Transferase P1-1","volume":"116","author":"De Luca","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B13","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41418-018-0252-y","article-title":"Autophagy-dependent Cell Death","volume":"26","author":"Denton","year":"2019","journal-title":"Cell Death Differ"},{"key":"B14","doi-asserted-by":"publisher","first-page":"E41","DOI":"10.1073\/pnas.1218065109","article-title":"DNA Damage Checkpoint Triggers Autophagy to Regulate the Initiation of Anaphase","volume":"110","author":"Dotiwala","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1200\/JCO.2004.07.184","article-title":"Phase III Trial of Doxorubicin Plus Cisplatin with or without Paclitaxel Plus Filgrastim in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study","volume":"22","author":"Fleming","year":"2004","journal-title":"Jco"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e00149","DOI":"10.1002\/prp2.149","article-title":"Analysis of Drug Combinations: Current Methodological Landscape","volume":"3","author":"Foucquier","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"B17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/0929867033368484","article-title":"Cisplatin Biochemical Mechanism of Action: From Cytotoxicity to Induction of Cell Death through Interconnections between Apoptotic and Necrotic Pathways","volume":"10","author":"Fuertes","year":"2003","journal-title":"Cmc"},{"key":"B18","first-page":"247","article-title":"A Study of the Interaction of the Hypnotic Effects and of the Toxic Effects of Chloral Hydrate and Ethanol","volume":"174","author":"Gessner","year":"1970","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1689-8","article-title":"ATR Mediates Cisplatin Resistance in 3D-Cultured Breast Cancer Cells via Translesion DNA Synthesis Modulation","volume":"10","author":"Gomes","year":"2019","journal-title":"Cell Death Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"117955491879056","DOI":"10.1177\/1179554918790563","article-title":"Survival Study of Triple-Negative and Non-triple-negative Breast Cancer in a Brazilian Cohort","volume":"12","author":"Gon\u00e7alves","year":"2018","journal-title":"Clin. Med. Insights Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1021\/cr900249z","article-title":"Fluorescent Indicators for Intracellular pH","volume":"110","author":"Han","year":"2010","journal-title":"Chem. Rev."},{"key":"B22","first-page":"727","article-title":"PD-1\/PD-L1 Pathway: Current Researches in Cancer","volume":"10","author":"Han","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/1479-5876-12-108","article-title":"A Phase \u0399I Study of Five Peptides Combination with Oxaliplatin-Based Chemotherapy as a First-Line Therapy for Advanced Colorectal Cancer (FXV Study)","volume":"12","author":"Hazama","year":"2014","journal-title":"J. Translational Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10555-021-09972-4","article-title":"Checkpoint Inhibitor Therapy for Metastatic Triple-Negative Breast Cancer","volume":"40","author":"Heeke","year":"2021","journal-title":"Cancer Metastasis Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"75571","DOI":"10.18632\/oncotarget.12289","article-title":"IL-1 Drives Breast Cancer Growth and Bone Metastasis In Vivo","volume":"7","author":"Holen","year":"2016","journal-title":"Oncotarget"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1002\/jcp.29274","article-title":"Role of Sonic Hedgehog Signaling in Cell Cycle, Oxidative Stress, and Autophagy of Temozolomide Resistant Glioblastoma","volume":"235","author":"Honorato","year":"2020","journal-title":"J. Cel Physiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1177\/107327481001700305","article-title":"A Review of Triple-Negative Breast Cancer","volume":"17","author":"Ismail-Khan","year":"2010","journal-title":"Cancer Control"},{"key":"B28","doi-asserted-by":"publisher","first-page":"819563","DOI":"10.3389\/fonc.2022.819563","article-title":"Clinical Applications and Anticancer Effects of Antimicrobial Peptides: From Bench to Bedside","volume":"12","author":"Jafari","year":"2022","journal-title":"Front. Oncol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.2217\/pgs-2017-0117","article-title":"Triple-negative Breast Cancer and the Potential for Targeted Therapy","volume":"18","author":"Jhan","year":"2017","journal-title":"Pharmacogenomics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","article-title":"Guidelines for the Use and Interpretation of Assays for Monitoring Autophagy (3rd Edition)","volume":"12","author":"Klionsky","year":"2016","journal-title":"Autophagy"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1007\/s00520-016-3080-y","article-title":"Chemotherapy-induced Nausea and Vomiting: Incidence and Characteristics of Persistent Symptoms and Future Directions NCCTG N08C3 (Alliance)","volume":"24","author":"Kottschade","year":"2016","journal-title":"Support Care Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/cdd.2008.150","article-title":"Classification of Cell Death: Recommendations of the Nomenclature Committee on Cell Death 2009","volume":"16","author":"Kroemer","year":"2009","journal-title":"Cel Death Differ"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.2147\/TCRM.S165531","article-title":"The Characteristics and Risk Factors for Cisplatin-Induced Acute Kidney Injury in the Elderly","volume":"14","author":"Liu","year":"2018","journal-title":"Tcrm"},{"key":"B34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40620-017-0392-z","article-title":"Cisplatin Nephrotoxicity: a Review of the Literature","volume":"31","author":"Manohar","year":"2018","journal-title":"J. Nephrol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00051","article-title":"Autophagy and the Cell Cycle: A Complex Landscape","volume":"7","author":"Mathiassen","year":"2017","journal-title":"Front. Oncol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"4978","DOI":"10.1093\/nar\/gkw246","article-title":"Insights into RNA Binding by the Anticancer Drug Cisplatin from the crystal Structure of Cisplatin-Modified Ribosome","volume":"44","author":"Melnikov","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of Cisplatin Nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins"},{"key":"B38","doi-asserted-by":"publisher","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination Therapy in Combating Cancer","volume":"8","author":"Mokhtari","year":"2017","journal-title":"Oncotarget"},{"key":"B39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"B40","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.ccr.2011.11.003","article-title":"IL-10 Elicits IFN\u03b3-dependent Tumor Immune Surveillance","volume":"20","author":"Mumm","year":"2011","journal-title":"Cancer Cell"},{"key":"B41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-3-319-26666-4_9","article-title":"Methods for Studying Autophagy within the Tumor Microenvironment","volume":"899","author":"Murugan","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.semcancer.2014.05.004","article-title":"Therapeutic Targeting of Autophagy in Cancer. Part I: Molecular Pathways Controlling Autophagy","volume":"31","author":"Nagelkerke","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-o","article-title":"A Rapid and Simple Method for Measuring Thymocyte Apoptosis by Propidium Iodide Staining and Flow Cytometry","volume":"139","author":"Nicoletti","year":"1991","journal-title":"J. Immunol. Methods"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.cell.2017.11.009","article-title":"Combination Cancer Therapy Can Confer Benefit via Patient-To-Patient Variability without Drug Additivity or Synergy","volume":"171","author":"Palmer","year":"2017","journal-title":"Cell"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14338","article-title":"mTORC1-independent TFEB Activation via Akt Inhibition Promotes Cellular Clearance in Neurodegenerative Storage Diseases","volume":"8","author":"Palmieri","year":"2017","journal-title":"Nat. Commun."},{"key":"B46","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.molonc.2012.02.003","article-title":"Hormonal Therapy in Breast Cancer: A Model Disease for the Personalization of Cancer Care","volume":"6","author":"Puhalla","year":"2012","journal-title":"Mol. Oncol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.3390\/ijms19103060","article-title":"Granulin A Synergizes with Cisplatin to Inhibit the Growth of Human Hepatocellular Carcinoma","volume":"19","author":"Qiao","year":"2018","journal-title":"Ijms"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00667","article-title":"LyeTxI-b, a Synthetic Peptide Derived from Lycosa Erythrognatha Spider Venom, Shows Potent Antibiotic Activity In Vitro and In Vivo","volume":"9","author":"Reis","year":"2018","journal-title":"Front. Microbiol."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2018\/e478s","article-title":"DNA Repair Pathways and Cisplatin Resistance: an Intimate Relationship","volume":"73","author":"Rocha","year":"2018","journal-title":"Clinics"},{"key":"B50","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00726-009-0385-x","article-title":"LyeTx I, a Potent Antimicrobial Peptide from the Venom of the Spider Lycosa Erythrognatha","volume":"39","author":"Santos","year":"2010","journal-title":"Amino Acids"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1126\/science.1204592","article-title":"TFEB Links Autophagy to Lysosomal Biogenesis","volume":"332","author":"Settembre","year":"2011","journal-title":"Science"},{"key":"B52","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4161\/auto.2703","article-title":"Autophagy, Bafilomycin and Cell Death: the \"A-B-Cs\" of Plecomacrolide-Induced Neuroprotection","volume":"2","author":"Shacka","year":"2006","journal-title":"Autophagy"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/srep35482","article-title":"Induction of Autophagy and Apoptosis via PI3K\/AKT\/TOR Pathways by Azadirachtin A in Spodoptera Litura Cells","volume":"6","author":"Shao","year":"2016","journal-title":"Sci. Rep."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1200\/JCO.2009.22.4725","article-title":"Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer","volume":"28","author":"Silver","year":"2010","journal-title":"Jco"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00174","article-title":"Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy","volume":"10","author":"Starobova","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2045-3701-4-7","article-title":"Combination Therapy of Anti-cancer Bioactive Peptide with Cisplatin Decreases Chemotherapy Dosing and Toxicity to Improve the Quality of Life in Xenograft Nude Mice Bearing Human Gastric Cancer","volume":"4","author":"Su","year":"2014","journal-title":"Cel Biosci."},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/0471141755.ph0919s72","article-title":"Drug Combinations: Tests and Analysis with Isoboles","volume":"72","author":"Tallarida","year":"2016","journal-title":"Curr. Protoc. Pharmacol."},{"key":"B58","doi-asserted-by":"crossref","DOI":"10.1201\/9781420036107","volume-title":"Drug Synergism and Dose-Effect Data Analysis","author":"Tallarida","year":"2000"},{"key":"B59","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1242\/jcs.195057","article-title":"Ratiometric Analysis of Acridine orange Staining in the Study of Acidic Organelles and Autophagy","volume":"129","author":"Thom\u00e9","year":"2016","journal-title":"J. Cel Sci"},{"key":"B60","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/annonc\/mdt540","article-title":"Cisplatin and Gemcitabine for Advanced Biliary Tract Cancer: a Meta-Analysis of Two Randomised Trials","volume":"25","author":"Valle","year":"2014","journal-title":"Ann. Oncol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"106","DOI":"10.7497\/j.issn.2095-3941.2015.0030","article-title":"Current Approaches in Treatment of Triple-Negative Breast Cancer","volume":"12","author":"Wahba","year":"2015","journal-title":"Cancer Biol. Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular Processing of Platinum Anticancer Drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.876833\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T07:29:45Z","timestamp":1651649385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.876833\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,4]]},"references-count":62,"alternative-id":["10.3389\/fmolb.2022.876833"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2022.876833","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,4]]},"article-number":"876833"}}